Seegene, Inc., a worldwide chief in molecular diagnostics (MDx), has established a brand new subsidiary in France to strengthen its European presence and assist international gross sales enlargement, the corporate introduced on Dec. 5.
The brand new subsidiary will strengthen native engagement with prospects and companions via enhanced technical assist, market growth and collaboration with healthcare stakeholders.
Based on international market analysis agency Grand View Analysis, Inc., France’s MDx market is estimated to achieve roughly EUR 600 million, accounting for round 15 p.c of Europe’s whole. It’s the second-largest market within the area after Germany, which holds a 19 p.c share. Demand in France is especially excessive for diagnostic checks focusing on sexually transmitted infections (STIs), gastrointestinal (GI) tract infections, and respiratory infections. By its subsidiary, Seegene goals to increase gross sales of those product strains whereas introducing a broader portfolio together with cervical most cancers and different multiplex diagnostic classes.
“On the French market, which is split between the non-public and public sectors, the flexibility to shortly ship revolutionary merchandise and meet laboratories’ effectivity wants is a key issue for competitiveness,” mentioned Daniel Shin, government vice chairman and chief international gross sales and advertising officer at Seegene. “The subsidiary will allow Seegene to realize a greater understanding of the French healthcare panorama, strengthening native customer support, and speed up the expansion of the corporate’s in vitro diagnostics enterprise with devoted native experience.”
The subsidiary additionally supplies a strategic foothold for the European rollout of Seegene’s options which are in growth, CURECA, a completely automated, unmanned PCR system, and STAgora, a real-time diagnostic information analytics and predictive insights platform.
The addition of France brings Seegene’s abroad gross sales subsidiaries to eight, complementing its international distribution community of 90 distributors throughout 94 nations.
As of the primary half of 2025, abroad gross sales accounted for roughly 93 p.c of Seegene’s whole income, with Europe representing 63 p.c. The area stays a key progress driver for the corporate’s international enlargement roadmap.
